Anticalins in Drug Development
Toward Personalized Immunotherapy for Non-Hodgkin Lymphoma
Mechanisms of Action for Treatments in Multiple Sclerosis
The Role of Radioimmunotherapy with Yttrium-90 Ibritumomab Tiuxetan in the Treatment of Non-Hodgkin Lymphoma
Spotlight on Subcutaneous Recombinant Interferon-β-1a (Rebif®) in Relapsing-Remitting Multiple Sclerosis1
Darbepoetin Alfa